The efficacy of homoeopathic remedies in the treatment of chronic allergies
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Chronic allergic conditions affect an estimated 30 to 40 percent of the global population and remain incompletely controlled by conventional antihistamine and corticosteroid therapy in a substantial minority of patients who continue to experience bothersome symptoms despite pharmacological optimization. Homoeopathic medicine offers an individualized constitutional approach that proponents argue can modulate allergic hypersensitivity at a fundamental level, yet rigorous clinical evidence supporting this claim remains limited and contested within mainstream medical literature. This research evaluated the efficacy of individualized homoeopathic remedies compared with placebo in adults with chronic allergic rhinitis, conjunctivitis, or atopic dermatitis through a double-blind randomized controlled trial conducted at two Swedish academic medical centers between April 2023 and October 2024. A total of 171 eligible participants were randomized in a one-to-one ratio to receive either individualized homoeopathic prescriptions selected through constitutional case-taking or identical placebo globules over a 12-month treatment period with monthly follow-up consultations. The primary outcome was the change in total symptom severity score measured on a validated 10-point composite scale at 12 months compared with baseline values. Secondary outcomes included individual symptom domain scores covering nasal congestion, sneezing frequency, ocular irritation, skin reactions, respiratory discomfort, and sleep disturbance, along with serum immunoglobulin E levels measured at baseline, six months, and 12 months, and quality-of-life assessments using the Rhinoconjunctivitis Quality of Life Questionnaire. At 12 months, the homoeopathic group demonstrated a mean reduction in total symptom severity of 3.4 points from a baseline of 7.2 compared with a 1.1-point reduction in the placebo group from a baseline of 7.1, yielding a between-group difference of 2.3 points that reached statistical significance at p less than 0.001. All six individual symptom domains showed greater improvement in the homoeopathic arm relative to placebo. Serum IgE levels declined by 18.7% in the treatment group versus just 4.2% in controls over the same period. No serious adverse events were recorded in either arm throughout the entire trial duration. These findings suggest that individualized homoeopathic treatment provides clinically meaningful symptom relief in chronic allergy patients beyond placebo effects, warranting larger multicenter confirmatory trials with extended post-treatment follow-up.
Fields of Study & Subjects
Complementary and Alternative Medicine Studies
Allergic Rhinitis and Sensitization
Asthma and respiratory diseases
Publication details
- Journal / source
- International Journal of Homoeopathic Sciences
- Volume
- 10
- Issue
- 1
- Pages
- 53–59
- Publication date
- 1 January 2026
- Language
- EN